STAGED EMBOLIZATION OF A DOUBLE ARTERIOVENOUS MALFORMATION IN ADULTS

A AHMED; . BAWNA; MI FARID; AI ABURABEE; SN AHMED; I AHMAD; AA KHAN

doi:10.54112/bcsrj.v2024i1.1178

Authors

A AHMED Department of Radiology, Fatima Jinnah Medical University, Lahore, Pakistan
. BAWNA Faculty of Medicine and Faculty of Surgery, Isra University, Hyderabad, Pakistan
MI FARID Department of Electrical and Computer Engineering, Air University, Islamabad, Pakistan
AI ABURABEE Centre of Medical Imaging, Faculty of Health Sciences, University Teknologi, MARA Selangor, Malaysia
SN AHMED Department Of Radiology, Sheikh Khalifa Bin Zayyed Hospital, Quetta, Pakistan
I AHMAD Niazi Medical and Dental College, Sargodha, Pakistan
AA KHAN Liaquat University of Medical & Health Sciences Jamshoro, Sindh, Pakistan

DOI:

https://doi.org/10.54112/bcsrj.v2024i1.1178

Keywords:

Arteriovenous Malformations, Embolization, Therapeutic, Interventional Neuroradiology, Vascular Anomalies, Vascular Malformations

Abstract

Arteriovenous malformations (AVMs) are rare vascular anomalies where abnormal connections form between arteries and veins, bypassing the capillary network that typically regulates blood flow. Objective: The study's main objective is to find the staged embolization of a double arteriovenous malformation in adults. Methods: This prospective observational study was conducted at Fatima Jinnah Medical University, Lahore, from January 2022 to January 2023. A total of 125 adult patients diagnosed with double AVMs were included in the study. Patients aged > 18 years and with confirmed double AVMs (detected on imaging), no previous AVM treatment, and who were eligible for embolization based on clinical and imaging findings were included in the study. Results: Data were collected from 125 patients with a mean age of 45.2 ± 5.46 years. The gender distribution was 56% male (70 patients) and 44% female (55 patients). The average size of the arteriovenous malformations (AVMs) was 4.8 cm, ranging from 2.5 to 6.5 cm. According to the Spetzler-Martin grading system, most patients were classified as Grade III (44%), followed by Grade II and IV (20% each), with 8% in both Grade I and V. The embolization treatment for the patients was conducted in multiple stages, with 40% undergoing 3 stages, 28% undergoing 4 stages, and 24% undergoing 2 stages. A smaller group (8%) required 5 stages of embolization. Onyx was the most commonly used embolic agent (64%), followed by n-butyl cyanoacrylate (28%) and coils (8%). The average interval between stages was 5.2 weeks. Conclusion: It is concluded that staged embolization is an effective and safe approach for managing double arteriovenous malformations (AVMs) in adults, offering high rates of occlusion while minimizing the risk of complications.

Downloads

Download data is not yet available.

References

Arkar U, Vesnaver TV, Gergeli AT, Bizjak N, Osredkar D. Children with Arteriovenous Malformations of the Central Nervous System: A Retrospective Study of 12 Pediatric Cases from a Single Tertiary Center in Slovenia. Medical Science Monitor: International Medical Journal of Experimental and Clinical Research. 2022;28:e936240-1.

El-Ghanem M, Kass-Hout T, Kass-Hout O, Alderazi YJ, Amuluru K, Al-Mufti F, et al. Arteriovenous malformations in the pediatric population: review of the existing literature. Interventional neurology. 2016;5(3-4):218-25.

De Leacy R, Ansari SA, Schirmer CM, Cooke DL, Prestigiacomo CJ, Bulsara KR, et al. Endovascular treatment in the multimodality management of brain arteriovenous malformations: report of the Society of NeuroInterventional Surgery Standards and Guidelines Committee. Journal of neurointerventional surgery. 2022;14(11):1118-24.

LoPresti MA, Ravindra VM, Pyarali M, Goethe E, Gadgil N, Wagner K, et al. Pediatric intracranial arteriovenous malformations: a single-center experience. Journal of Neurosurgery: Pediatrics. 2019;25(2):151-8.

Hartmann A, Mast H, Mohr JP, Pile-Spellman J, Connolly ES, Sciacca RR, et al. Determinants of staged endovascular and surgical treatment outcome of brain arteriovenous malformations. Stroke. 2005;36(11):2431-5.

Iizuka Y, Rodesch G, Garcia-Monaco R, Alvarez H, Burrows P, Hui F, et al. Multiple cerebral arteriovenous shunts in children: report of 13 cases. Child's Nervous System. 1992;8:437-44.

Chen C-C, Cho YD, Yoo DH, Moon J, Lee J, Kang H-S, et al. Endovascular management of multiple intracranial dural arteriovenous fistulas. Journal of Neuroradiology. 2019;46(6):390-7.

Willinsky R, Lasjaunias P, Terbrugge K, Burrows P. Multiple cerebral arteriovenous malformations (AVMs) Review of our experience from 203 patients with cerebral vascular lesions. Neuroradiology. 1990;32:207-10.

Ha S, Kwon Y, Kim B, Kim D, Kim DJ. Clinical and angiographic characteristics of multiple dural arteriovenous shunts. American journal of neuroradiology. 2012;33(9):1691-5.

Baharvahdat H, Blanc R, Fahed R, Smajda S, Ciccio G, Desilles J-P, et al. Endovascular treatment for low-grade (Spetzler-Martin I–II) brain arteriovenous malformations. American Journal of Neuroradiology. 2019;40(4):668-72.

Morgan M, Zurin A, Harrington T, Little N. Changing role for preoperative embolisation in the management of arteriovenous malformations of the brain. Journal of clinical neuroscience. 2000;7(6):527-30.

Sato K, Matsumoto Y, Tominaga T, Satow T, Iihara K, Sakai N. Complications of endovascular treatments for brain arteriovenous malformations: a nationwide surveillance. American Journal of Neuroradiology. 2020;41(4):669-75.

Donzelli GF, Nelson J, McCoy D, McCulloch CE, Hetts SW, Amans MR, et al. The effect of preoperative embolization and flow dynamics on resection of brain arteriovenous malformations. Journal of neurosurgery. 2019;132(6):1836-44.

Starke RM, Komotar RJ, Otten ML, Hahn DK, Fischer LE, Hwang BY, et al. Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits. Stroke. 2009;40(8):2783-90.

Catapano JS, Frisoli FA, Nguyen CL, Wilkinson DA, Majmundar N, Cole TS, et al. Spetzler-Martin grade III arteriovenous malformations: a multicenter propensity-adjusted analysis of the effects of preoperative embolization. Neurosurgery. 2021;88(5):996-1002.

Wong J, Slomovic A, Ibrahim G, Radovanovic I, Tymianski M. Microsurgery for ARUBA trial (A Randomized Trial of Unruptured Brain Arteriovenous Malformation)–eligible unruptured brain arteriovenous malformations. Stroke. 2017;48(1):136-44.

Pan P, Weinsheimer S, Cooke D, Winkler E, Abla A, Kim H, et al. Review of treatment and therapeutic targets in brain arteriovenous malformation. Journal of Cerebral Blood Flow & Metabolism. 2021;41(12):3141-56.

Ivanov AA, Alaraj A, Charbel FT, Aletich V, Amin-Hanjani S. Recurrence of cerebral arteriovenous malformations following resection in adults: does preoperative embolization increase the risk? Neurosurgery. 2016;78(4):562-71.